[go: up one dir, main page]

IT1177501B - Resinato di un acido carbossilico sosituito, procedimento per la sua preparazione, suo impiego e preparati farmaceutici che contengono questo - Google Patents

Resinato di un acido carbossilico sosituito, procedimento per la sua preparazione, suo impiego e preparati farmaceutici che contengono questo

Info

Publication number
IT1177501B
IT1177501B IT47527/84A IT4752784A IT1177501B IT 1177501 B IT1177501 B IT 1177501B IT 47527/84 A IT47527/84 A IT 47527/84A IT 4752784 A IT4752784 A IT 4752784A IT 1177501 B IT1177501 B IT 1177501B
Authority
IT
Italy
Prior art keywords
resinate
procedure
contain
preparation
carboxylic acid
Prior art date
Application number
IT47527/84A
Other languages
English (en)
Other versions
IT8447527A0 (it
Inventor
Satish Chandra Khanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IT8447527A0 publication Critical patent/IT8447527A0/it
Application granted granted Critical
Publication of IT1177501B publication Critical patent/IT1177501B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/44Preparation of metal salts or ammonium salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT47527/84A 1983-01-12 1984-01-10 Resinato di un acido carbossilico sosituito, procedimento per la sua preparazione, suo impiego e preparati farmaceutici che contengono questo IT1177501B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH14783A CH655507B (it) 1983-01-12 1983-01-12

Publications (2)

Publication Number Publication Date
IT8447527A0 IT8447527A0 (it) 1984-01-10
IT1177501B true IT1177501B (it) 1987-08-26

Family

ID=4180317

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47527/84A IT1177501B (it) 1983-01-12 1984-01-10 Resinato di un acido carbossilico sosituito, procedimento per la sua preparazione, suo impiego e preparati farmaceutici che contengono questo

Country Status (41)

Country Link
US (1) US4510128A (it)
EP (1) EP0122219B1 (it)
JP (1) JPS59134759A (it)
KR (1) KR900006747B1 (it)
AR (1) AR240310A1 (it)
AT (2) AT391467B (it)
AU (1) AU570230B2 (it)
BE (1) BE898649A (it)
CA (1) CA1218077A (it)
CH (1) CH655507B (it)
CS (1) CS269954B2 (it)
DD (1) DD218373A5 (it)
DE (2) DE3474152D1 (it)
DK (1) DK166683B1 (it)
DZ (1) DZ593A1 (it)
EG (1) EG16562A (it)
ES (1) ES8504849A1 (it)
FI (1) FI82682C (it)
FR (1) FR2542735B1 (it)
GB (1) GB2134529B (it)
GR (1) GR79793B (it)
HK (1) HK90390A (it)
HU (1) HU190750B (it)
IE (1) IE56545B1 (it)
IL (1) IL70660A (it)
IT (1) IT1177501B (it)
LU (1) LU85171A1 (it)
MA (1) MA20000A1 (it)
MC (1) MC1564A1 (it)
MT (1) MTP943B (it)
NL (1) NL8400098A (it)
NO (1) NO162862C (it)
NZ (1) NZ206815A (it)
OA (1) OA07628A (it)
PH (1) PH21795A (it)
PL (1) PL142737B1 (it)
PT (1) PT77932B (it)
RO (1) RO88481A (it)
SE (1) SE457959B (it)
ZA (1) ZA84212B (it)
ZW (1) ZW484A1 (it)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
US5230885A (en) * 1987-12-23 1993-07-27 Smith Kline & French Laboratories Limited Polystyrene anion exchange polymer pharmaceutical composition
AU608114B2 (en) * 1987-12-23 1991-03-21 Smith Kline & French Laboratories Limited Compounds
CH675537A5 (it) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
ES2054089T3 (es) * 1988-11-10 1994-08-01 Ciba Geigy Ag Formulaciones orales liquidas.
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
GB8913700D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
SE9004129D0 (sv) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech Anion exchanger
EP0592569A1 (en) * 1991-07-03 1994-04-20 Sano Corporation Composition and method for transdermal delivery of diclofenac
EP1250937B1 (en) * 2001-04-09 2009-05-13 Rohm And Haas Company Controlled dissolution of active ingredients
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
US20080095842A1 (en) * 2004-12-06 2008-04-24 Antarkar Amit K Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations
RU2435569C2 (ru) 2006-03-16 2011-12-10 Трис Фарма, Инк. Композиции с модифицированным высвобождением, содержащие комплексы лекарственное вещество - ионообменная смола
US7799347B2 (en) 2006-09-07 2010-09-21 Chondrex Inc. Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases
AU2009298112B2 (en) * 2008-10-02 2015-11-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Administration of an adsorbent polymer for treatment of systemic inflammation
JP5968300B2 (ja) 2010-03-24 2016-08-10 ジャズ、ファーマシューティカルズ、インコーポレイテッドJazz Pharmaceuticals Inc. 高用量、水溶性及び吸湿性薬剤基質用の制御放出性剤形
EP2884961B1 (en) 2012-08-15 2019-03-06 Tris Pharma Inc. Methylphenidate extended release chewable tablet
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
CA3115122A1 (en) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
CN113473980A (zh) 2019-03-01 2021-10-01 弗拉梅尔爱尔兰有限公司 在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
GB823000A (en) * 1957-10-03 1959-11-04 Clinical Products Ltd Resin-drug compounds
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3316282A (en) * 1965-02-08 1967-04-25 Squibb & Sons Inc Anion exchange resin complex of a cycloborate ester of a steroid
FI49600C (fi) * 1967-12-20 1975-08-11 Ciba Geigy Ag Menetelmä substituoitujen fenyylietikkahappojen ja näiden suolojen val mistamiseksi.
CH519476A (de) * 1968-03-30 1972-02-29 Hoechst Ag Verfahren zur Herstellung von Salzen von Acylamino-alkylbenzolsulfonyl-harnstoffen mit Anionenaustauschern
US3926864A (en) * 1971-06-21 1975-12-16 Ionics Ion exchange membranes having a macroporous surface area
GB1423694A (en) * 1973-07-10 1976-02-04 Beecham Group Ltd Pharmaceutical compositions
US4058491A (en) * 1975-02-11 1977-11-15 Plastomedical Sciences, Inc. Cationic hydrogels based on heterocyclic N-vinyl monomers
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
US4217421A (en) * 1977-06-27 1980-08-12 Rohm And Haas Company Anion exchange resins prepared from crosslinked polystyrenesulfonylchloride
US4380590A (en) * 1978-09-19 1983-04-19 Rohm And Haas Company Emulsion copolymer cation exchange resins
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
US4207399A (en) * 1979-03-14 1980-06-10 Rohm And Haas Company Methylquinoline high polymer based on quaternary ammonium polymers
US4302548A (en) * 1980-05-22 1981-11-24 Rohm And Haas Company Production of ion exchange resins, the resins so produced and ion exchange processes using them

Also Published As

Publication number Publication date
FR2542735A1 (fr) 1984-09-21
AU2323084A (en) 1984-07-19
DK11884D0 (da) 1984-01-11
EP0122219A2 (de) 1984-10-17
BE898649A (fr) 1984-07-11
EP0122219B1 (de) 1988-09-21
GB2134529A (en) 1984-08-15
MC1564A1 (fr) 1984-11-12
GB8400251D0 (en) 1984-02-08
GB2134529B (en) 1986-09-24
HU190750B (en) 1986-10-28
IE56545B1 (en) 1991-08-28
AT391467B (de) 1990-10-10
ES528770A0 (es) 1985-05-01
FI82682B (fi) 1990-12-31
IL70660A (en) 1987-08-31
PH21795A (en) 1988-02-29
MTP943B (en) 1984-06-05
EG16562A (en) 1991-12-30
NO162862B (no) 1989-11-20
PT77932B (en) 1986-07-22
ES8504849A1 (es) 1985-05-01
MA20000A1 (fr) 1984-10-01
CS269954B2 (en) 1990-05-14
IL70660A0 (en) 1984-04-30
DE3400491A1 (de) 1984-07-12
DK166683B1 (da) 1993-06-28
DZ593A1 (fr) 2004-09-13
ZW484A1 (en) 1984-08-08
ATE37378T1 (de) 1988-10-15
CS17884A2 (en) 1989-10-13
PL142737B1 (en) 1987-11-30
FI82682C (fi) 1991-04-10
SE8400098D0 (sv) 1984-01-10
FI840069A0 (fi) 1984-01-09
PL245656A1 (en) 1985-01-02
HUT34151A (en) 1985-02-28
FI840069A (fi) 1984-07-13
NO840090L (no) 1984-07-13
JPS59134759A (ja) 1984-08-02
FR2542735B1 (fr) 1986-04-18
HK90390A (en) 1990-11-09
AU570230B2 (en) 1988-03-10
LU85171A1 (de) 1984-10-24
SE457959B (sv) 1989-02-13
NO162862C (no) 1990-02-28
KR900006747B1 (ko) 1990-09-20
DD218373A5 (de) 1985-02-06
RO88481A (ro) 1986-01-30
ZA84212B (en) 1984-08-29
DE3400491C2 (it) 1988-11-10
GR79793B (it) 1984-10-31
PT77932A (en) 1984-02-01
SE8400098L (sv) 1984-07-13
CA1218077A (en) 1987-02-17
US4510128A (en) 1985-04-09
IT8447527A0 (it) 1984-01-10
DK11884A (da) 1984-07-13
NL8400098A (nl) 1984-08-01
OA07628A (fr) 1985-05-23
JPH0257058B2 (it) 1990-12-03
DE3474152D1 (en) 1988-10-27
NZ206815A (en) 1986-08-08
CH655507B (it) 1986-04-30
IE840049L (en) 1984-07-12
EP0122219A3 (en) 1985-05-08
AR240310A1 (es) 1990-03-30
KR840007562A (ko) 1984-12-08
ATA784A (de) 1990-04-15

Similar Documents

Publication Publication Date Title
IT1177501B (it) Resinato di un acido carbossilico sosituito, procedimento per la sua preparazione, suo impiego e preparati farmaceutici che contengono questo
IT1153315B (it) Preparazioni di insulina stabilizzate e un procedimento per la loro preparazione
DK257485D0 (da) Farmaceutiske praeparater til oral indgift
NL190581B (nl) 7beta-(d-2-amino-2-fenylaceetamido)-3-(propenyl)-3-cefem-4-carbonzuur verbinding en farmaceutisch preparaat dat deze verbinding omvat.
IT8719165A0 (it) Derivato di acido tiazolidin-4-carbossilico, sua preparazione e composizioni farmaceutiche che lo contengono.
IT1150499B (it) Acidi ossazafosforin-4-tio-alcansolfonici,loro sali neutri,procedimento per la loro preparazione e preparati farmaceutici che li contengono
IT8247797A0 (it) Sale diammonico di un acido carbossilico sostituito, procedimento per la sua preparazione, suo impiego e preparati farmaceutici
ITMI911059A1 (it) Acido metiltauroursodesossicolico e suoi derivati terapeuticamente attivi procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
DK489384D0 (da) 6alfa-(1-hydroxyethyl)-2-(dioxacycloalkyl)alkylthio-2-penem-3-carboxylsyre-forbindelser og farmaceutisk praeparat
DK489584D0 (da) 6alfa-(1-hydroxyethyl)-2-azacycloalkylthio-2-penem-3-carboxylsyre-forbindelser og farmaceutisk praeparat
DK99085A (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
IT1196162B (it) Sale di due-piperazinopirimidina,procedimento per la sua preparazione e composizioni farmaceutiche che ne contengono
IT8448789A1 (it) Composti amminometilici procedimento per produrli preparati farmaceutici che li contengono
IT1120970B (it) Derivato di acido penicillanico e procedimento per la sua preparazione
IT1185513B (it) Procedimento per l'ottenimento di preparati farmaceutici con effetto ritardato
IT1183766B (it) Composti pteridinici relativi procedimenti di preparazione e preparati farmaceutici che li contengono
IT8448807A0 (it) Sale di d,l-lisina dell'acido 1-(4clorobenzoil)-5-metossi-2-metil-1hindol-3 acetico, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT8248068A0 (it) Derivato dell'acido 2-(4-isobutilfenil)-proprionico, procedimento per la sua fabbricazione e composizioni farmaceutiche che lo contengono
IT8521662A0 (it) Derivato dell'acido chinolin-3-carbossilico, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono.
IT1163108B (it) Sale di eritromicina dell'acido benzoico-o-carboniltiazolidina,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT8167171A0 (it) Derivato dell acido 2 4 isobutilfenil propionico particolarmente utile come antinfiammatorio e procedimento per la sua preparazione
IT8620072A0 (it) Sale dell'acido 2',4'-difluoro-4-idrossi-3-bifenilcarbossilico, sua preparazione e composizioni farmaceutiche che lo contengono.
IT8421275A0 (it) Derivato dell'acido 2-(3-benzoil-fenil)propionico, procedimento per la sua preparazione e forme farmaceutiche contenenti lo stesso.
GR80434B (en) 7b-acylamido-3-cephem -4-carbon acid ester, method for the preparation thereof pharmaceutical preparations containing them and use thereof
IT8125878A0 (it) Estere dell'acido 2-[5'-(p-clorobenzoil)-1',4'-dimetil-2'-pirrolil]acetico, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono.